Strados Labs Announces Pediatric Asthma Study to Validate its Wearable Device in Children with Wheeze
Strados Labs’ RESP™ Biosensor is currently being used in a clinical trial at Lurie Children’s to determine if it can accurately detect wheezing in children.
Labs
PHILADELPHIA, PA, UNITED STATES, September 26, 2023 /EINPresswire.com/ — Strados Labs has partnered with Ann & Robert H. Lurie Children’s Hospital of Chicago for a clinical trial to evaluate the effectiveness of its RESP™ Biosensor in children presenting with wheeze. The RESP™ Biosensor – a novel wearable device used to remotely monitor lung sounds for asthma symptoms such as coughing and wheezing – will be evaluated against a 3M™ Littman digital stethoscope used for episodic auscultation.
